Handheld Device Detects Alzheimer's Biomarkers; Long COVID Smell Loss; MS Fatigue

— News and commentary from the world of neurology and neuroscience

MedicalToday
Neuro Break over a computer rendering of neurons.

A handheld wireless device using a graphene field-effect transistor sensor amyloid beta, tau, and alpha-synuclein. (Proceedings of the National Academy of Sciences)

Whistleblowers suggested that a University of Southern California neuroscientist that supported a major stroke trial and blood-brain barrier research. (Science)

Loss of over 3 years in long COVID patients who had mild acute SARS-CoV-2 infection. (JAMA Otolaryngology-Head and Neck Surgery)

A pragmatic trial showed that people with Parkinson's disease and related disorders who had a reported better quality of life at 6 months and were more likely to complete advance directives. (JAMA Neurology)

A in multiple sclerosis (MS), a small trial showed. (Multiple Sclerosis Journal)

Blood-based biomarkers in primary progressive MS. (Journal of Neurology, Neurosurgery, and Psychiatry)

Molecular biomarkers have been linked to but none are used clinically, a review showed. (Nature Reviews Neurology)

The autism-linked gene SYNGAP1 of human brain development. (Nature Neuroscience)

Boston University's Ann McKee, MD, is on a mission to save brains from (CTE) by making contact sports safer. (Wired)

"Seinfeld" episodes between a brain region that helped people enjoy a joke and another that helped them get it. (Journal of Neuroscience)

  • Judy George covers neurology and neuroscience news for , writing about brain aging, Alzheimer’s, dementia, MS, rare diseases, epilepsy, autism, headache, stroke, Parkinson’s, ALS, concussion, CTE, sleep, pain, and more.